Cart

0

Stocks

“Goldman Sachs: 2 Stocks That Could Climb Over 90%”

Athira Pharma (ATHA)

Judging by the consensus breakdown, opinions are anything but mixed. With 4 Buys and no Holds or Sells assigned in the last three months, the word on the Street is that ATHA is a Strong Buy. At $42.50, the average price target implies 132% upside potential…

Denali Therapeutics (DNLI)

Looking at the consensus breakdown, 6 Buys and 2 Holds have been issued in the last three months. Therefore, DNLI gets a Strong Buy consensus rating. Based on the $51.17 average price target, shares could surge 16% in the next year…”

https://finance.yahoo.com/news/goldman-sachs-2-stocks-could-150019682.html

Leave a Reply